1. |
Minato H, Nakanuma Y, Terada T. Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts [J]. Histopathology, 1996; 28(5)∶411.
|
2. |
Maestranzi S, Przemioslo R, Mitchell H, et al. The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA [J]. Ann Clin Biochem, 1998; 35(Pt 1)∶99.
|
3. |
Paganuzzi M, Onetto M, Marroni P, et al. CA19-9 and CA50 in benign and malignant pancreatic and biliary diseases [J]. Cancer, 1988; 61(10)∶2100.
|
4. |
秦兴雷, 李志强, 石景森, 等. 血清和胆汁CA19-9联合检测对诊断胆道良恶性病变的价值 [J]. 中国普外基础与临床杂志, 2000; 7(3)∶161.
|
5. |
Bjornsson E, Kilander A, Olsson R. CA19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis [J]. Liver, 1999; 19(6)∶501.
|
6. |
Patel AH, Harnois DM, Klee GG, et al. The utility of CA19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis [J]. Am J Gastroenterol, 2000; 95(1)∶204.
|
7. |
Robertson AG, Davidson BR. Mirizzi syndrome complicating an anomalous biliary tract: a novel cause of a hugely elevated CA19-9 [J]. Eur J Gastroenterol Hepatol, 2007; 19(2)∶167.
|
8. |
Murray MD, Burton FR, Di Bisceglie AM. Markedly elevated serum CA19-9 levels in association with a benign biliary stricture due to primary sclerosing cholangitis [J]. J Clin Gastroenterol, 2007; 41(1)∶115.
|
9. |
Katsanos KH, Kitsanou M, Christodoulou DK, et al. High CA19-9 levels in benign biliary tract diseases. Report of four cases and review of the literature [J]. Eur J Intern Med, 2002; 13(2)∶132.
|
10. |
Albert MB, Steinberg WM, Henry JP. Elevated serum levels of tumor marker CA19-9 in acute cholangitis [J]. Dig Dis Sci, 1988; 33(10)∶1223.
|
11. |
Lin CL, Changchien CS, Chen YS. Mirizzi’s syndrome with a high CA19-9 level mimicking cholangiocarcinoma [J]. Am J Gastroenterol, 1997; 92(12)∶2309.
|
12. |
Ogawa T, Yokoi H, Kawarada Y. A case of inflammatory pseudotumor of the liver causing elevated serum CA19-9 levels [J]. Am J Gastroenterol, 1998; 93(12)∶2551.
|
13. |
Trompetas V, Panagopoulos E, Ramantanis G. Gall-bladder agenesis presenting with obstructive jaundice and elevated CA19-9 [J]. Acta Chir Belg, 2004; 104(3)∶347.
|
14. |
Basso D, Meggiato T, Fabris C, et al. Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases [J]. Eur J Clin Invest, 1992; 22(12)∶800.
|